36 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
or outstanding long-term indebtedness of the Company or its Subsidiary or (v) any dividend or distribution of any kind declared, paid or made … on Indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
our common stock under the constructive sale provisions of the Code; and
certain U.S. expatriates and certain former citizens or long-term residents … the amount realized and the U.S. Holder’s adjusted tax basis in such common stock. Any such capital gain or loss generally will constitute long-term capital
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
provisions of the Code; and
certain U.S. expatriates and certain former citizens or long-term residents of the United States.
In addition … tax basis in such common stock. Any such capital gain or loss generally will constitute long-term capital gain or loss if the U.S. Holder’s holding
8-K
EX-10.1
yc2mpynz3bcajgxvqa
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
sva quqgk72n
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-1.2
oryhztnyi0s3fyh0k8
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
33a2nauy cffbwrry
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
x4338jubn az
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
10xb324yj
20 Oct 22
Draft registration statement
12:00am
DEF 14A
xv9f2 850yr
25 Apr 22
Definitive proxy
5:28pm
10-K
awqa sfkgfcan
30 Mar 22
Annual report
7:40am
10-Q
i4cmz8hp 6s
17 Nov 21
Quarterly report
5:15pm